🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To study the effect of fractionated 1927-nm non ablative thulium laser in r...
Status
Recruiting
Location
Henry Ford Medical Center
Start Date
2023-11-15
Trial ID
NCT06149780
Treatments Being Tested
The objective of this clinical study is to compare the safety and efficacy ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-07-01
Trial ID
NCT05129254
Melasma is a hyperpigmentary disorder of the skin especially of the face. C...
Status
Completed
Location
The second affiliated hospital of Xi'an Jiaotong University
Start Date
2023-04-01
Trial ID
NCT06313307
Treatments Being Tested
The purpose of this study is to determine the efficacy of lidocaine 2.5%/pr...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2021-01-08
Trial ID
NCT04523961
Atrophic acne scars (AAS) is one of the most common skin sequelae following...
Status
Completed
Location
1927-Nm Fractional Thulium Fiber Laser
Start Date
2025-01-01
Trial ID
NCT07305675
Treatments Being Tested
Atrophic acne scars are common disfiguring skin problems, especially in the...
Status
Completed
Location
The second affiliated hospital of Xi'an Jiaotong University
Start Date
2021-01-01
Trial ID
NCT07153679
Treatments Being Tested
The Multimodal Laser Project is a prospective, randomized, split-face clini...
Status
Not Yet Recruiting
Location
Department of Dermatology, Bispebjerg Hospital
Start Date
2026-09-01
Trial ID
NCT07789002
Treatments Being Tested
The purpose of this study is to compare two treatments for acne scars on th...
Status
Recruiting
Location
Espaço Conceito Medical San
Start Date
2025-10-16
Trial ID
NCT07151599
Treatments Being Tested
Purpose: 1927nm fractional thulium fiber laser (TFL) has been shown to be e...
Status
Completed
Location
The Second Affiliated Hospital of Xi'an Jiao Tong University
Start Date
2023-06-01
Trial ID
NCT06925035
Treatments Being Tested